SUBSCRIPTION AGREEMENT
Exhibit 10.3
Execution Copy
Gentlemen:
The undersigned (the “Investor”) hereby confirms its agreement with Harvest Natural Resources,
Inc., a Delaware corporation (the “Company”), as follows:
1. This Subscription Agreement, including the Terms and Conditions for Purchase of Securities
attached hereto as Annex I (collectively, this “Agreement”) is made as of the date set
forth below between the Company and the Investor.
2. The Company has authorized the sale and issuance to certain investors of up to an aggregate
of $32,000,000 principal amount of the Company’s 8.25% Senior Convertible Notes due 2013 (the
“Notes”), which are convertible (at the initial conversion rate specified in the Indenture and the
Notes, under the circumstances and subject to adjustment as set forth in the Indenture, into shares
(the “Conversion Shares”) of common stock, par value $0.01 per share (the “Common Stock”) of the
Company in accordance with the terms of the Notes and the Indenture to be dated as of the Closing
Date (the “Indenture”) between the Company and U.S. Bank National Association, as trustee (the
“Trustee”), as supplemented by a supplemental indenture to be dated the Closing Date. The Notes
and the Conversion Shares are collectively referred to herein as the “Securities.”
3. The offering and sale of the Securities (the “Offering”) are being made pursuant to (a) an
effective Registration Statement on Form S-3, No. 333-162858 (the “Registration Statement”) filed
by the Company with the Securities and Exchange Commission (the “Commission”), including the
Prospectus contained therein (the “Base Prospectus”), (b) if applicable, certain “free writing
prospectuses” (as that term is defined in Rule 405 under the Securities Act of 1933, as amended
(the “Act”)), that have been or will be filed, if required, with the Commission and delivered to
the Investor on or prior to the date hereof (the “Issuer Free Writing Prospectus”), containing
only certain supplemental information regarding the Securities, the terms of the Offering and the
Company, (c) if applicable, a Preliminary Prospectus Supplement (the “Preliminary Prospectus
Supplement”) containing certain supplemental information regarding the Securities, the terms of the
Offering and the Company and (d) a Prospectus Supplement (the “Prospectus Supplement” and, together
with the Base Prospectus, the “Prospectus”) containing only certain supplemental information
regarding the Securities and terms of the Offering that has been or will be filed with the
Commission and delivered to the Investor prior to the Closing.
4. The Company and the Investor agree that the Investor will purchase from the Company and the
Company will issue and sell to the Investor the principal amount of the Notes set forth below for
the aggregate purchase price set forth below. The Notes shall be purchased pursuant to the Terms
and Conditions for Purchase of Notes attached hereto as Annex I and incorporated herein by
this reference as if fully set forth herein. The Investor acknowledges that the Offering is not
being
underwritten by the placement agents (the “Placement Agents”) named in the Prospectus
Supplement and that there is no minimum offering amount.
5. The manner of settlement of the Notes:
The notes will be issued in fully registered book-entry form and will be represented by
one or more permanent global notes without coupons. The global notes will be deposited
with a custodian for and registered in the name of Cede & Co. as The Depository Trust
Company (“DTC”) nominee. Delivery versus payment (“DVP”) through DTC (i.e., on
the Closing Date, the Company shall deliver Notes registered in the Investor’s name and
address as set forth below and released by the Trustee to the Investor through DTC at the
Closing directly to the account(s) at Lazard Capital Markets LLC (“LCM”) identified by
the Investor; upon receipt of such Notes, LCM shall promptly electronically deliver such
Notes to the Investor, and simultaneously therewith payment shall be made by LCM by wire
transfer to the Company). NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS
AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:
| (I) | NOTIFY LCM OF THE ACCOUNT OR ACCOUNTS AT LCM TO BE CREDITED WITH THE NOTES BEING PURCHASED BY SUCH INVESTOR, AND | ||
| (II) | CONFIRM THAT THE ACCOUNT OR ACCOUNTS AT LCM TO BE CREDITED WITH THE NOTES BEING PURCHASED BY THE INVESTOR HAVE A MINIMUM BALANCE EQUAL TO THE AGGREGATE PURCHASE PRICE FOR THE SECURITIES BEING PURCHASED BY THE INVESTOR. |
IT IS THE INVESTOR’S RESPONSIBILITY TO (A) MAKE THE NECESSARY WIRE TRANSFER OR CONFIRM THE
PROPER ACCOUNT BALANCE IN A TIMELY MANNER AND (B) ARRANGE FOR SETTLEMENT BY WAY OF DVP IN A TIMELY
MANNER. IF THE INVESTOR DOES NOT DELIVER THE AGGREGATE PURCHASE PRICE FOR THE NOTES OR DOES NOT
MAKE PROPER ARRANGEMENTS FOR SETTLEMENT IN A TIMELY MANNER, THE NOTES MAY NOT BE DELIVERED AT
CLOSING TO THE INVESTOR OR THE INVESTOR MAY BE EXCLUDED FROM THE CLOSING ALTOGETHER.
6. The Notes shall be delivered in accordance with the terms thereof.
7. The Investor represents that, except as set forth below, (a) it has had no position, office
or other material relationship within the past three years with the Company or persons known to it
to be affiliates of the Company, (b) it is not a Financial Industry Regulatory Authority member or
an Associated Person (as such term is defined under the NASD Membership and Registration Rules
Section 1011) as of the Closing, and (c) neither the Investor nor any group of Investors (as
identified in a public filing made with the Commission) of which the Investor is a part in
connection with the Offering of the Securities, has acquired, or obtained the right to acquire, 20%
or more of the Common Stock (or securities convertible into or exercisable for Common Stock) or the
voting power of the Company on a post-transaction basis. Exceptions:
-2-
(If no exceptions, write “none.” If left blank, response will be deemed to be “none.”)
8. The Investor represents that it has received (or otherwise had made available to it by the
filing by the Company of an electronic version thereof with the Commission), the Preliminary
Prospectus Supplement, including the Base Prospectus which is a part of the Company’s Registration
Statement, the documents incorporated by reference therein and any free writing prospectus
(collectively, the “Disclosure Package”), prior to or in connection with the receipt of this
Agreement. The Investor acknowledges that, prior to the delivery of this Agreement to the Company,
the Investor will receive certain additional information regarding the Offering, including the
pricing information (the “Offering Information”). Such information may be provided to the Investor
by any means permitted under the Act, including the Prospectus Supplement, a free writing
prospectus and oral communications.
9. No offer by the Investor to buy the Notes will be accepted and no part of the Purchase
Price will be delivered to the Company until the Investor has received the Disclosure Package and
the Offering Information and the Company has accepted such offer by countersigning a copy of this
Agreement, and any such offer may be withdrawn or revoked, without obligation or commitment of any
kind, at any time prior to the Company (or Placement Agents on behalf of the Company) sending
(orally, in writing or by electronic mail) notice of its acceptance of such offer. An indication
of interest will involve no obligation or commitment of any kind until the Investor has been
delivered the Disclosure Package and the Offering Information and this Agreement is accepted and
countersigned by or on behalf of the Company.
10. The Company acknowledges that the only material, non-public information relating to the
Company it has provided to the Investor in connection with the Offering prior to the date hereof is
the existence of the Offering and the Preliminary Prospectus Supplement, which will be filed with
the Commission prior to the opening of the New York Stock Exchange on February 11, 2010.
-3-
Principal Dollar Amount of Notes:
$_____________________
Please confirm that the foregoing correctly sets forth the agreement between us by signing in
the space provided below for that purpose.
| Dated as of: February ___, 2010 |
| INVESTOR |
| By: | ||||
| Print Name: | ||||
| Title: | ||||
| Address: | ||||||
Agreed and Accepted
this ___ day of February, 2010:
this ___ day of February, 2010:
| HARVEST NATURAL RESOURCES, INC. |
||||
| By: | ||||
| Title: | ||||
-4-
ANNEX I
TERMS AND CONDITIONS FOR PURCHASE OF SECURITIES
1. Authorization and Sale of the Securities. Subject to the terms and conditions of this
Agreement, the Company has authorized the sale of the Notes.
2. Agreement to Sell and Purchase the Securities; Placement Agents.
2.1 At the Closing (as defined in Section 3.1), the Company will sell to the Investor,
and the Investor will purchase from the Company, upon the terms and conditions set forth herein,
the principal amount of Notes set forth on the signature page of the Agreement to which these Terms
and Conditions for Purchase of Securities are attached as Annex I (the “Signature Page”)
for the aggregate purchase price therefor set forth on the Signature Page.
2.2 The Company anticipates that other investors (the “Other Investors”) will participate in
the Offering, and expects to complete sales of Notes to them. The Company agrees that such Other
Investors will execute substantially the same form of Subscription Agreement as this Agreement.
The Investor and the Other Investors are hereinafter sometimes collectively referred to as the
“Investors,” and this Agreement and the Subscription Agreements executed by the Other Investors are
hereinafter sometimes collectively referred to as the “Agreements.”
2.3 The Investor acknowledges that the Company has agreed to pay Lazard Capital Markets LLC
(“LCM”) and Xxxxxxx Xxxxxxxx and Company, LLC (“MWC”, and together with LCM, the “Placement
Agents”) a fee (the “Placement Fee”) of six percent (6.0%) in respect of the sale of Notes to the
Investor.
2.4 The Company has entered into a Placement Agent Agreement, dated the date hereof (the
“Placement Agreement”), with the Placement Agents that contains certain representations,
warranties, covenants and agreements of the Company that may be relied upon by the Investor, which
shall be a third party beneficiary thereof.
2.5 The Company will enter into an Indenture to be dated as of the Closing Date between the
Company and U.S. Bank, N.A., as Trustee, as supplemented by the supplemental indenture to be dated
as of the Closing Date, pursuant to which the Notes will be issued.
3. Closing and Delivery of the Notes and Funds.
3.1 Closing. The completion of the purchase and sale of the Notes (the “Closing”)
shall occur at a place and time (the “Closing Date”) to be specified by the Company and the
Placement Agents, and of which the Investors will be notified in advance by the Placement Agents,
in accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). At the Closing, (a) the Company shall cause the Trustee to deliver to the
account of the Investor a Note for the principal amount set forth on the Signature Page registered
in the name of the Investor or, if so indicated on the Investor Questionnaire attached hereto as
Exhibit A, in the name of a nominee designated by the Investor and (b) the aggregate
purchase price for the Notes being purchased by the Investor will be delivered by or on behalf of
the Investor to the Company.
-5-
3.2 Conditions to the Obligations of the Parties.
(a) Conditions to the Company’s Obligations. The Company’s obligation to issue and
sell the Notes to the Investor shall be subject to: (i) the receipt by the Company of the purchase
price for the Notes being purchased hereunder as set forth on the Signature Page and (ii) the
accuracy of the representations and warranties made by the Investor and the fulfillment of those
undertakings of the Investor to be fulfilled prior to the Closing Date.
(b) Conditions to the Investor’s Obligations. The Investor’s obligation to purchase
the Notes will be subject to the accuracy of(x) the representations and warranties made by the
Company in this Agreement and the Placement Agreement shall be true and correct as of the date
hereof and as of the Closing Date and the Company shall have fulfilled those undertakings of the
Company required to be fulfilled prior to the Closing Date, including without limitation, those
contained in the Placement Agreement, and (y) that the Placement Agents shall not have: (i)
terminated the Placement Agreement pursuant to the terms thereof or (ii) determined that the
conditions to the closing in the Placement Agreement have not been satisfied. The Investor’s
obligations are expressly not conditioned on the purchase by any or all of the Other Investors of
the Notes that they have agreed to purchase from the Company. The Investor understands and agrees
that, in the event that LCM, in behalf of the Placement Agents, in its sole discretion determines
that the conditions to closing in the Placement Agreement have not been satisfied or if the
Placement Agreement may be terminated for any other reason permitted by the Placement Agreement,
then LCM may, but shall not be obligated to, terminate the Placement Agreement, which shall have
the effect of terminating this Subscription Agreement pursuant to Section 14 below. The
Placement Agents shall not have the authority to amend or modify the Company’s representations and
warranties set forth in Section 3 of the Placement Agreement or the closing conditions
contained in Section 7 of the Placement Agreement in a manner adverse to the Investor or
waive any provisions or conditions contained therein without the consent of the Investor.
3.3 Delivery of Funds.
Delivery Versus Payment through The Depository Trust Company. No later than one
(1) business day after the execution of this Agreement by the Investor and the Company, the
Investor shall confirm that the account or accounts at LCM to be credited with the Notes being
purchased by the Investor have a minimum balance equal to the aggregate purchase price for the
Notes being purchased by the Investor.
3.4 Delivery of Notes.
Delivery Versus Payment through The Depository Trust Company. No later than one
(1) business day after the execution of this Agreement by the Investor and the Company, the
Investor shall notify LCM of the account or accounts at LCM to be credited with the Notes being
purchased by such Investor. On the Closing Date, the Company shall deliver the Notes to the
Investor through DTC directly to the account(s) at LCM identified by Investor and simultaneously
therewith payment shall be made by LCM by wire transfer to the Company.
-6-
4. Representations, Warranties and Covenants of the Investor.
The Investor acknowledges, represents and warrants to, and agrees with, the Company and the
Placement Agents (as to themselves) that:
4.1 The Investor (a) is knowledgeable, sophisticated and experienced in making, and is
qualified to make decisions with respect to, investments in shares presenting an investment
decision like that involved in the purchase of the Notes, including investments in securities
issued by the Company and investments in comparable companies, (b) has provided all information on
the Signature Page and the Investor Questionnaire and the answers thereto are true and correct as
of the date hereof and will be true and correct as of the Closing Date and (c) in connection with
its decision to purchase the principal amount of Notes set forth on the Signature Page, has
received and is relying only upon the Disclosure Package and the documents incorporated by
reference therein and the Offering Information.
4.2 (a) No action has been or will be taken in any jurisdiction outside the United States by
the Company or the Placement Agents that would permit an offering of the Securities, or possession
or distribution of offering materials in connection with the issue of the Securities in any
jurisdiction outside the United States where action for that purpose is required, (b) if the
Investor is outside the United States, it will comply with all applicable laws and regulations in
each foreign jurisdiction in which it purchases, offers, sells or delivers Securities or has in its
possession or distributes any offering material, in all cases at its own expense and (c) the
Placement Agents are not authorized to make and has not made any representation, disclosure or use
of any information in connection with the issue, placement, purchase and sale of the Securities,
except as set forth or incorporated by reference in the Base Prospectus or the Prospectus or any
free writing prospectus.
4.3 (a) The Investor has full right, power, authority and capacity to enter into this
Agreement and to consummate the transactions contemplated hereby and has taken all necessary action
to authorize the execution, delivery and performance of this Agreement, and (b) this Agreement
constitutes a valid and binding obligation of the Investor enforceable against the Investor in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting
parties’ rights generally and except as enforceability may be subject to general principles of
equity (regardless of whether such enforceability is considered in a proceeding in equity or at
law) and except as to the enforceability of any rights to indemnification or contribution that may
be violative of the public policy underlying any law, rule or regulation (including any federal or
state securities law, rule or regulation).
4.4 The Investor understands that nothing in this Agreement, the Prospectus, the Disclosure
Package, the Offering Information or any other materials presented to the Investor in connection
with the purchase and sale of the Securities constitutes legal, tax or investment advice. The
Investor has consulted such legal, tax and investment advisors and made such investigation as it,
in its sole discretion, has deemed necessary or appropriate in connection with its purchase of
Securities. The Investor also understands that there is no established public trading market
for the Notes being offered in the Offering, and that the Company does not expect such a market to
develop. In addition, the Company does not intend to apply for listing the Notes on any securities
exchange. Without an active market, the liquidity of the Notes will be limited.
4.5 Since the date on which the Placement Agents first contacted the Investor about
-7-
the Offering, the Investor has not disclosed any information regarding the Offering to any
third parties (other than its legal, accounting and other advisors) and has not engaged in any
purchases or sales involving the securities of the Company (including, without limitation, any
Short Sales involving the Company’s securities). The Investor covenants that it will not engage in
any purchases or sales involving the securities of the Company (including Short Sales) prior to the
time that the transactions contemplated by this Agreement are publicly disclosed. The Investor
agrees that it will not use any of the Securities acquired pursuant to this Agreement to cover any
short position in the Common Stock if doing so would be in violation of applicable securities laws.
For purposes hereof, “Short Sales” include, without limitation, all “short sales” as defined in
Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box,
and all types of direct and indirect stock pledges, forward sales contracts, options, puts, calls,
short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under the Exchange Act)
and similar arrangements (including on a total return basis), and sales and other transactions
through non-US broker dealers or foreign regulated brokers.
5. Survival of Representations, Warranties and Agreements; Third Party Beneficiary.
Notwithstanding any investigation made by any party to this Agreement or by the Placement Agents,
all covenants, agreements, representations and warranties made by the Company and the Investor
herein will survive the execution of this Agreement, the delivery to the Investor of the Securities
being purchased and the payment therefor. The Placement Agents and Lazard Fréres & Co. shall be
third party beneficiaries with respect to the representations, warranties and agreements of the
Investor in Section 4 hereof.
6. Notices. All notices, requests, consents and other communications hereunder will be in
writing, will be mailed (a) if within the domestic United States by first-class registered or
certified airmail, or nationally recognized overnight express courier, postage prepaid, or by
facsimile or (b) if delivered from outside the United States, by International Federal Express or
facsimile, and (c) will be deemed given (i) if delivered by first-class registered or certified
mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized
overnight carrier, one business day after so mailed, (iii) if delivered by International Federal
Express, two business days after so mailed and (iv) if delivered by facsimile, upon electronic
confirmation of receipt and will be delivered and addressed as follows:
(a) if to the Company, to:
Harvest Natural Resources, Inc.
0000 Xxxxxxx Xxxxxxx, Xxxxx 000
Xxxxxxx, Xxxxx 00000
Attention: Xxxxx X. Head, Vice President and General Counsel
Facsimile: (000) 000-0000
0000 Xxxxxxx Xxxxxxx, Xxxxx 000
Xxxxxxx, Xxxxx 00000
Attention: Xxxxx X. Head, Vice President and General Counsel
Facsimile: (000) 000-0000
-8-
with copies to:
Fulbright & Xxxxxxxx L.L.P.
0000 Xxxx Xxxxxx, Xxxxx 0000
Xxxxxx, Xxxxx 00000
Attention: Xxxxx X. Xxxxxxx
Facsimile: (000) 000-0000
0000 Xxxx Xxxxxx, Xxxxx 0000
Xxxxxx, Xxxxx 00000
Attention: Xxxxx X. Xxxxxxx
Facsimile: (000) 000-0000
(b) if to the Investor, at its address on the Signature Page hereto, or at such
other address or addresses as may have been furnished to the Company in writing.
7. Changes. This Agreement may not be modified or amended except pursuant to an instrument
in writing signed by the Company and the Investor.
8. Headings. The headings of the various sections of this Agreement have been inserted for
convenience of reference only and will not be deemed to be part of this Agreement.
9. Severability. In case any provision contained in this Agreement should be invalid,
illegal or unenforceable in any respect, the validity, legality and enforceability of the
remaining provisions contained herein will not in any way be affected or impaired thereby.
10. Governing Law. This Agreement will be governed by, and construed in accordance with,
the internal laws of the State of New York, without giving effect to the principles of
conflicts of law that would require the application of the laws of any other jurisdiction.
11. Counterparts. This Agreement may be executed in two or more counterparts, each of which
will constitute an original, but all of which, when taken together, will constitute but one
instrument, and will become effective when one or more counterparts have been signed by each
party hereto and delivered to the other parties. The Company and the Investor acknowledge
and agree that the Company shall deliver its counterpart to the Investor along with the
Prospectus Supplement (or the filing by the Company of an electronic version thereof with
the Commission).
12. Confirmation of Sale. The Investor acknowledges and agrees that such Investor’s receipt
of the Company’s signed counterpart to this Agreement, together with the Prospectus
Supplement (or the filing by the Company of an electronic version thereof with the
Commission), shall constitute written confirmation of the Company’s sale of Notes to such
Investor.
13. Press Release. The Company and the Investor agree that the Company shall, prior to the
opening of the financial markets in New York City on the business day immediately after the
date hereof, (a) issue a press release announcing the Offering and disclosing all material
information regarding the Offering and (b) file a Current Report on Form 8-K with the
Securities and Exchange Commission including a form of this Agreement, form of Note and
supplemental indenture as exhibits thereto. Notwithstanding the foregoing, the Company
shall not publicly disclose the name of the Investor or any affiliate or investment adviser
of the Investor, or include the name of the Investor or any affiliate or investment adviser
of any Investor in any press release or filing with the Securities and Exchange Commission
or any regulatory agency or trading market, without the prior written consent of such
Investor, except
-9-
(i) as required by federal securities law and (ii) to the extent such disclosure is required
by law or trading market regulations, in which case the Company shall provide the Investor
with prior written notice of such disclosure permitted under this sub-clause (ii). As of
the issuance of the press release described above, the Investor shall not be in possession
of any material, non public information received from the Company (other than as set forth
in Section 10 on page 3 of this Agreement), any subsidiary of the Company or any of
their respective officers, directors or employees.
14. Termination. In the event that the Placement Agreement is terminated by the Placement
Agents pursuant to the terms thereof, this Agreement shall terminate without any further
action on the part of the parties hereto. The Investor shall have the right to terminate
this Agreement if the Closing has not occurred on or before February 19, 2010.
-10-
Exhibit A
INVESTOR QUESTIONNAIRE
Pursuant to Section 3 of Annex I to the Agreement, please provide us with the
following information:
1.
|
The exact name that your Notes are to be registered in. You may use a nominee name if appropriate: | |||
2.
|
The relationship between the Investor and the registered holder listed in response to item 1 above: | |||
3.
|
The mailing address of the registered holder listed in response to item 1 above: | |||
4.
|
The Social Security Number or Tax Identification Number of the registered holder listed in the response to item 1 above: | |||
5.
|
Name of DTC Participant (broker-dealer at which the account or accounts to be credited with the Notes are maintained): | |||
6.
|
DTC Participant Number: | |||
7.
|
Name of Account at DTC Participant being credited with the Notes: | |||
8.
|
Account Number at DTC Participant being credited with the Notes: |
